Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2022-06-29
Original market date: See footnote 1
2014-04-14
Product name:
DERACIN 22% GRANULAR PREMIX
DIN:
02407558
Product Monograph/Veterinary Labelling:
Date:
2018-01-29
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHARMGATE INC.
1800 Sir Tyler Drive
Wilmington
North Carolina
United States
28405
Class:
Veterinary
Species:
Cattle , Swine (pigs)
Dosage form(s):
Drug Premix
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0105527010
Active ingredient(s) | Strength |
---|---|
CHLORTETRACYCLINE HYDROCHLORIDE (CHLORTETRACYCLINE CALCIUM COMPLEX) | 220 G / Kg |